Concepedia

Anna-Karin Sohlenius-Sternbeck

AS

16

Publications

765

Citations

14

H-Index

2000

Active since

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (United Kingdom)

Karolinska Institutet

Medivir (Sweden)

RISE Research Institutes of Sweden

Anna-Karin Sohlenius-Sternbeck is an author at AstraZeneca (Sweden) specializing in medicine, metabolomics, and health sciences.

Top concepts

Publications per year

2000–2022

16

Publications

16

Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements

Anna-Karin Sohlenius-Sternbeck · Toxicology in Vitro · 2006 · 250 citations

, , +17

Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds

Anna-Karin Sohlenius-Sternbeck, Lovisa Afzelius, Peteris Prūsis et al. · Xenobiotica · 2010 · 127 citations

, , +16

Practical use of the regression offset approach for the prediction of<i>in vivo</i>intrinsic clearance from hepatocytes

Anna-Karin Sohlenius-Sternbeck, Chris Jones, Douglas Ferguson et al. · Xenobiotica · 2012 · 92 citations

Evaluation of ADMET Predictor in Early Discovery Drug Metabolism and Pharmacokinetics Project Work

Anna-Karin Sohlenius-Sternbeck, Ylva Terelius · Drug Metabolism and Disposition · 2021 · 63 citations · Full text

The Impact of Solute Carrier (SLC) Drug Uptake Transporter Loss in Human and Rat Cryopreserved Hepatocytes on Clearance Predictions

Patrik Lundquist, Johan Lööf, Anna-Karin Sohlenius-Sternbeck et al. · Drug Metabolism and Disposition · 2014 · 39 citations

Rows per page

1–5 of 16